GlassScriptPhysician profile
Garrett H Brown
NPI 1588001432
$10,296.02
in general payments reported to CMS, 2019-2025
40 companies · $1,481 in 2025
The $1,481 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,753 · 2020: $465 · 2021: $1,641 · 2022: $1,640 · 2023: $1,041 · 2024: $1,276 · 2025: $1,481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,797.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $2,483.29 | 2019-2024 | Orsiro Mission, Nhancer Rx |
| Abbott Laboratories | $2,006.48 | 2019-2025 | Ultreon, Diamondback Coronary, Coroflow |
| Abiomed | $1,365.98 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $561.24 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $453.54 | 2020-2025 | Lifevest |
| Pfizer INC. | $340.55 | 2021-2025 | |
| Impulse Dynamics (USA) INC. | $325.72 | 2023-2024 | Optimizer, Optimizer |
| Cardiovascular Systems INC. | $300.73 | 2020-2023 | Diamondback Coronary |
| Shockwave Medical, INC | $288.87 | 2025 | |
| Amgen INC. | $224.65 | 2021-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $201.41 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $198.24 | 2021-2025 | Verquvo |
| Terumo Medical Corporation | $159.32 | 2021-2025 | Metacross Otw |
| Janssen Pharmaceuticals, INC | $143.86 | 2019-2022 | |
| Reflow Medical INC | $114.56 | 2023-2024 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garrett Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.